Literature DB >> 8748927

cAMP-dependent protein kinase in cerebral microvessels in aging and Alzheimer disease.

R E Cashman1, P Grammas.   

Abstract

The purpose of this study was to compare the effects of aging and Alzheimer disease (AD) on the important intracellular signaling enzyme cAMP-dependent protein kinase A (PKA) in cerebral microvessels. PKA activity and levels were measured in microvessels isolated from the brains of adult and aged rodents as well as from the cerebral cortices of AD and elderly control patients. The results showed that cerebral microvessels from aged rats have significantly (p < 0.01) higher PKA activity and levels when compared to cerebral microvessels from adult rats. In contrast, no significant difference was found between PKA activity or levels in cerebral microvessels from AD patients when compared to controls. These results indicate that in cerebral microvessels both PKA activity and levels increase with age but are unaffected by AD. The data suggest that protein phosphorylation in brain microvessels may be affected differentially by aging and dementia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8748927     DOI: 10.1007/BF02815141

Source DB:  PubMed          Journal:  Mol Chem Neuropathol        ISSN: 1044-7393


  5 in total

Review 1.  Senescent-induced dysregulation of cAMP/CREB signaling and correlations with cognitive decline.

Authors:  Rolf T Hansen; Han-Ting Zhang
Journal:  Brain Res       Date:  2013-04-25       Impact factor: 3.252

Review 2.  Cyclic nucleotide signaling changes associated with normal aging and age-related diseases of the brain.

Authors:  Michy P Kelly
Journal:  Cell Signal       Date:  2017-11-23       Impact factor: 4.315

3.  Cerebrovascular transforming growth factor-beta contributes to inflammation in the Alzheimer's disease brain.

Authors:  Paula Grammas; Roma Ovase
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

4.  Microvessels from Alzheimer's disease brains kill neurons in vitro.

Authors:  P Grammas; P Moore; P H Weigel
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

Review 5.  Phosphodiesterase Inhibitors for Alzheimer's Disease: A Systematic Review of Clinical Trials and Epidemiology with a Mechanistic Rationale.

Authors:  Owen Sanders; Lekshmy Rajagopal
Journal:  J Alzheimers Dis Rep       Date:  2020-06-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.